← Back to RKDA

Arcadia Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 07/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 07/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 08/05/2025
$1.4$1.1$1.3$1.5$1.2$1.5$1.3$1
−$6.3−$4.4$0.9−$4.5$2.6−$1.6$1.1−$2.4
−$2.09−$2.11$0.62−$3.26$1.90−$1.18$0.78−$1.78
32.11.41.41.41.41.41.4

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.